Skip to main content
(720) 399-9322
Become a Provider
Hit enter to search or ESC to close
Close Search
Menu
Find a Provider
Patients
Providers
Provider Portals
Billing Intelligence Service
Become A Medicare Provider
Medical Billing
Packages
AireO2
Become a Provider
Leadership
Investor Relations
SEC Filings
Governance
News
Connect
Blog
Vivos in The News
Explore The Stories
Menu
Investor Relations
Leadership
Financial Results & SEC Filings
Stock Prices
Governance
News + Events
Filter
News
Vivos Announces Strategic Initiatives Aimed at Accelerating Timeline for Cash Flow Positive Operations
Clinical Study Shows 92% Resolution of Migraines Using Vivos’ POD®
Vivos Reports Fourth Quarter & Full Year 2022 Financial Results & Operational Update
Vivos Therapeutics to Participate in Fireside Chat at the 35th Annual ROTH Conference
Vivos Expands Revenue Potential with Acquisition of Product Rights & Patents from Advanced Facialdontics
Vivos Therapeutics to Present at the Emerging Growth Conference
Vivos Therapeutics Regains Compliance with Nasdaq Listing Requirements
Vivos Therapeutics Closes $8 Million Private Placement
Vivos Therapeutics Announces Pricing of $8 Million Private Placement
Close Menu
(720) 399-9322
Find a Provider
Patients
Providers
Provider Portals
Billing Intelligence Service
Become A Medicare Provider
Medical Billing
Packages
AireO2
Become a Provider
Leadership
Investor Relations
SEC Filings
Governance
News
Connect
Blog
Become a Provider
